Civic Intelligence

Institute for Rare and Neglected Diseases Drug Discovery

990EZ • Fiscal year 2013 • EIN 27-2797284

Jan 01, 2013 to Dec 31, 2013 • Filed on Aug 02, 2014

Organization Profilewww.irnd3.org
1514 Ridge Road94002

(650) 995-4270

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

93rd percentile

0.83x

Higher debt load relative to assets than 93% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Liabilities / Revenue

88th percentile

0.26x

Higher debt load relative to revenue than 88% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Net Margin

36th percentile

-2.2%

Higher net margin than 36% of similar nonprofits.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Top Officer Pay

82nd percentile

$20,000

Higher top officer pay than 82% of similar nonprofits.

Top officer pay equals 17.2% of source-year revenue.

2013 filings • 501(c)3 • <$500k nonprofits • Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Balance Sheet
Liabilities / Assets93rd percentile

Assets

$35,982

No earlier filing loaded for comparison.

Net Assets

$5,982

No earlier filing loaded for comparison.

Liabilities

$30,000

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / Revenue88th percentileNet Margin36th percentile

Revenue

$116,541

No earlier filing loaded for comparison.

Expenses

$119,082

No earlier filing loaded for comparison.

Net Income

-$2,541

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

Asset GrowthScore unavailable

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$150K$100K$50K$0-$50KAssets 2013: $35,982Liabilities 2013: $30,000Net Assets 2013: $5,9822013Assets 2014: $45,864Liabilities 2014: $46,369Net Assets 2014: -$5052014Assets 2015: $29,924Liabilities 2015: $30,850Net Assets 2015: -$9262015Assets 2016: $31,875Liabilities 2016: $30,000Net Assets 2016: $1,8752016Assets 2017: $104,494Liabilities 2017: $0Net Assets 2017: $104,4942017

Highlighted filing

2013

Assets$35,982
Liabilities$30,000
Net Assets$5,982
Open 2013 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$300K$200K$100K$0-$100KRevenue 2013: $116,541Expenses 2013: $119,082Net Income 2013: -$2,5412013Revenue 2014: $279,759Expenses 2014: $286,246Net Income 2014: -$6,4872014Revenue 2015: $323,549Expenses 2015: $323,970Net Income 2015: -$4212015Revenue 2016: $173,843Expenses 2016: $171,042Net Income 2016: $2,8012016Revenue 2017: $146,586Expenses 2017: $43,967Net Income 2017: $102,6192017

Highlighted filing

2013

Revenue$116,541
Expenses$119,082
Net Income-$2,541
Open 2013 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Signed
Aug 2, 2014
Return Version
2013v3.1
Gross Receipts
$116,541
Mission and Program Overview

Mission

Conduct research to identify and discover new medicines for rare and neglected diseases.

Program Services

DescriptionGrantsExpenses
AFRICAN SLEEPING SICKNESS. The accomplishments included receiving a 3-year award from NIH to establish assays to discover medicines for African Sleeping Sickness and successfully completing the work required for the first year of the grant. This included establishing assays for 3 drug targets and identifying new numbers of compounds that showed activity.Our goal for this project is to combat the neglected tropical infection human African Trypanosomiasis (HAT) by translating basic science discovery into therapeutics. By the end of the three-year period we expect to have new understandings and methodologies to identify novel chemicals that can be developed into cures for HAT. Thus, we anticipate that the short-term funding provided by the NIH will have a long-term impact on one of the most challenging and harmful diseases in the World.$41,679-
RARE PEDIATRIC CANCERS. iRND3 also established a platform to discover medicines for cancers evaluating cancers from melanoma cells. This screening platform is being applied to identify potential new chemical therapies for pediatric cancers including neuroblastoma and acute myeloid leukemia (AML) as well as breast cancer.Our goal for this project is to combat childhood cancer by translating basic science discovery into therapeutics. We expect to identify new understandings and methodologies to identify novel chemicals that can be developed into cures for childhood cancers. Thus, we anticipate that the short-term research and funding will have a long term impact for treating children with cancer that currently have few medical options.$41,679-
Compensation and Service Providers
Top Officer Pay82nd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
David SwinneyCEOFT$20,000-$20,000
Ahvie HerskovitzChairman-$0--
Paul NakagakiBoard Member-$0--
Paul GaterSecretary-$0--
Narinder BanaitTreasurer-$0--
Filing and Contact Details

Filer

EIN
27-2797284
Phone
6509954270

Signing Officer

Name
David Swinney
Title
CEO
Signed
2014-08-02
Discuss with paid preparer
Yes

Preparer

Preparer
Harmon Burstyn
Phone
9252863522
Supplemental Narrative

Additional Explanations

Grants and Similar Amounts Paid In Excess of $5,000.1

“| Donee's Name: Un. of GA Research Foundation, Inc. | Donee's Address: 200 D.W. Brooks Drive Athens, GA 30602 | Relationship of Donee: None | Cash Amount Given: $21829”

Grants and Similar Amounts Paid In Excess of $5,000.2

“| Donee's Name: Medhus Bio, Inc. | Donee's Address: 897 Independence Avenue Mountain View, CA 94043 | Relationship of Donee: None | Cash Amount Given: $10865”

Other Expenses.1002

“Office Expenses $246”

Other Expenses.1003

“Information Technology $1117”

Other Expenses.1012

“Insurance $215”

Other Expenses.1

“Lab Supplies $19893”

Other Expenses.2

“Protein Materials $8980”

Other Expenses.3

“Relocation $2280”

Other Expenses.4

“Small Equip/Furn/Fixtures $2038”

Other Expenses.5

“Licenses & Fees $1112”

Other Expenses.6

“Bank Fees $105”

Other Expenses.7

“Board Appreciation $54”

Other Assets.1

“Security Deposit - Beginning $0 Security Deposit - Ending $1200”

Total Liabilities.1

“Loan - Beginning $50000 Loan - Ending $30000”

Raw XML Appendix187 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0David Swinney
IRS990EZ/BooksInCareOfDetail/PhoneNum06509954270
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine101514 Ridge Road
IRS990EZ/BooksInCareOfDetail/USAddress/City0Belmont
IRS990EZ/BooksInCareOfDetail/USAddress/State0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCode094002
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt058523
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt034782
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0116500
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-2541
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt03030
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form720FiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt058523
IRS990EZ/Form990TotalAssetsGrp/EOYAmt035982
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt032694
IRS990EZ/GrossReceiptsAmt0116541
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/InvestmentIncomeAmt041
IRS990EZ/LoansToFromOfficersAmt030000
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0true
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt08523
IRS990EZ/NetAssetsOrFundBalancesEOYAmt05982
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt08523
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt05982
IRS990EZ/OccupancyRentUtltsAndMaintAmt09133
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt460.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt420000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Ahvie Herskovitz
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Paul Nakagaki
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Paul Gater
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Narinder Banait
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4David Swinney
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Chairman
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4CEO
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationFiled990TInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/EOYAmt01200
IRS990EZ/OtherExpensesTotalAmt036040
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Conduct research to identify and discover new medicines for rare and neglected diseases.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0AFRICAN SLEEPING SICKNESS. The accomplishments included receiving a 3-year award from NIH to establish assays to discover medicines for African Sleeping Sickness and successfully completing the work required for the first year of the grant. This included establishing assays for 3 drug targets and identifying new numbers of compounds that showed activity.Our goal for this project is to combat the neglected tropical infection human African Trypanosomiasis (HAT) by translating basic science discovery into therapeutics. By the end of the three-year period we expect to have new understandings and methodologies to identify novel chemicals that can be developed into cures for HAT. Thus, we anticipate that the short-term funding provided by the NIH will have a long-term impact on one of the most challenging and harmful diseases in the World.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1RARE PEDIATRIC CANCERS. iRND3 also established a platform to discover medicines for cancers evaluating cancers from melanoma cells. This screening platform is being applied to identify potential new chemical therapies for pediatric cancers including neuroblastoma and acute myeloid leukemia (AML) as well as breast cancer.Our goal for this project is to combat childhood cancer by translating basic science discovery into therapeutics. We expect to identify new understandings and methodologies to identify novel chemicals that can be developed into cures for childhood cancers. Thus, we anticipate that the short-term research and funding will have a long term impact for treating children with cancer that currently have few medical options.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt041679
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt141679
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/RelatedOrgSect527OrgInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt038185
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt050000
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt030000
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0119082
IRS990EZ/TotalProgramServiceExpensesAmt083358
IRS990EZ/TotalRevenueAmt0116541
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.irnd3.org
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0116500
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt035000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt035000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0186500
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt041
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt041
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.00000
IRS990ScheduleA/PublicSupportTotal170Amt0186500
IRS990ScheduleA/SubstantialContributorsTotAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0116500
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt035000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt035000
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0186500
IRS990ScheduleA/TotalSupportAmt0186541
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt030000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0Capital
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt050000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0Paul Nakagaki
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0Board
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/TotalBalanceDueAmt030000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0| Donee's Name: Un. of GA Research Foundation, Inc. | Donee's Address: 200 D.W. Brooks Drive Athens, GA 30602 | Relationship of Donee: None | Cash Amount Given: $21829
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1| Donee's Name: Medhus Bio, Inc. | Donee's Address: 897 Independence Avenue Mountain View, CA 94043 | Relationship of Donee: None | Cash Amount Given: $10865
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Office Expenses $246
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Information Technology $1117
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Insurance $215
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5Lab Supplies $19893
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6Protein Materials $8980
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7Relocation $2280
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8Small Equip/Furn/Fixtures $2038
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt9Licenses & Fees $1112
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt10Bank Fees $105
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt11Board Appreciation $54
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt12Security Deposit - Beginning $0 Security Deposit - Ending $1200
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt13Loan - Beginning $50000 Loan - Ending $30000
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Grants and Similar Amounts Paid In Excess of $5,000.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Grants and Similar Amounts Paid In Excess of $5,000.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.1003
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.1012
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc9Other Expenses.5
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc10Other Expenses.6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc11Other Expenses.7
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc12Other Assets.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc13Total Liabilities.1
ReturnHeader/BuildTS02015-11-30 17:44:51Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0David Swinney
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/SignatureDt02014-08-02
ReturnHeader/Filer/BusinessName/BusinessNameLine10Institute for Rare and Neglected
ReturnHeader/Filer/BusinessName/BusinessNameLine20Diseases Drug Discovery
ReturnHeader/Filer/BusinessNameControlTxt0INST
ReturnHeader/Filer/EIN0272797284
ReturnHeader/Filer/PhoneNum06509954270
ReturnHeader/Filer/USAddress/AddressLine101514 Ridge Road
ReturnHeader/Filer/USAddress/City0Belmont
ReturnHeader/Filer/USAddress/State0CA
ReturnHeader/Filer/USAddress/ZIPCode094002
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine10HARMON BURSTYN CPA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine101012 HACIENDA DR
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/City0WALNUT CREEK
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/State0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCode0945984710
ReturnHeader/PreparerPersonGrp/PhoneNum09252863522
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Harmon Burstyn
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02014-08-02T09:23:01-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02013-01-01
ReturnHeader/TaxPeriodEndDt02013-12-31
ReturnHeader/TaxYr02013

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2013 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$35,982
Liabilities
$30,000
Net assets
$5,982
Revenue
$116,541
Expenses
$119,082
Net income
-$2,541
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2017Detailed filing. Detailed filing data is available for this year.$1.04$0.00$1.04$1.47$0.44$1.03
2016Detailed filing. Detailed filing data is available for this year.$0.32$0.30$0.02$1.74$1.71$0.03
2015Detailed filing. Detailed filing data is available for this year.$0.30$0.31$0.01$3.24$3.24$0.00
2014Detailed filing. Detailed filing data is available for this year.$0.46$0.46$0.01$2.80$2.86$0.06
2013Detailed filing. Detailed filing data is available for this year.$0.36$0.30$0.06$1.17$1.19$0.03